Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Surmodics Inc (SRDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 774,434
  • Shares Outstanding, K 13,350
  • Annual Sales, $ 81,340 K
  • Annual Income, $ -4,460 K
  • 36-Month Beta 0.90
  • Price/Sales 9.54
  • Price/Cash Flow 84.07
  • Price/Book 7.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -110.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.39 +4.81%
on 11/15/18
68.84 -14.15%
on 11/08/18
-3.40 (-5.44%)
since 10/15/18
3-Month
56.39 +4.81%
on 11/15/18
82.35 -28.23%
on 09/04/18
-13.50 (-18.60%)
since 08/15/18
52-Week
25.00 +136.40%
on 02/09/18
82.35 -28.23%
on 09/04/18
+29.95 (+102.74%)
since 11/15/17

Most Recent Stories

More News
Surmodics' (SRDX) Q4 Earnings and Revenues Beat Estimates

Surmodics (SRDX) sees solid segmental performance in fiscal Q4; gains from alliance with Abbott.

ABT : 70.73 (+1.90%)
SYK : 168.72 (+1.64%)
SRDX : 59.10 (+1.88%)
ISRG : 513.64 (+3.01%)
SurModics (SRDX) Surpasses Q4 Earnings and Revenue Estimates

SurModics (SRDX) delivered earnings and revenue surprises of 600.00% and 2.21%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

SRDX : 59.10 (+1.88%)
Surmodics Reports Fourth Quarter Fiscal 2018 Results and Issues Fiscal 2019 Guidance

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2018 fourth quarter...

SRDX : 59.10 (+1.88%)
12-Month Data from Surmodics SurVeil(R) Drug-Coated Balloon Early Feasibility Study Presented at VIVA 2018

--Results demonstrated continued clinically significant improvement in ABI, walking distance, walking speed and stair-climbing scores at 12 months

SRDX : 59.10 (+1.88%)
Analysts Estimate SurModics (SRDX) to Report a Decline in Earnings: What to Look Out for

SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SRDX : 59.10 (+1.88%)
Surmodics Names Teri Sides as Chief Marketing Officer

Surmodics, Inc.(NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today Teri Sides has joined Surmodics as Senior...

SRDX : 59.10 (+1.88%)
Investor Expectations to Drive Momentum within Pacific Ethanol, CorVel, Surmodics, Alpha and Omega Semiconductor, MYOS RENS Technology, and Golden Entertainment -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Pacific Ethanol, Inc. (NASDAQ:PEIX),...

PEIX : 1.60 (-0.62%)
MYOS : 1.19 (+0.85%)
SRDX : 59.10 (+1.88%)
GDEN : 15.45 (+3.69%)
AOSL : 10.79 (+1.12%)
CRVL : 64.75 (+2.96%)
Wright Medical (WMGI) Takes Over Cartiva for $435M in Cash

The Cartiva buyout will boost Wright Medical's (WMGI) Lower Extremities business.

WMGI : 28.64 (+1.13%)
SRDX : 59.10 (+1.88%)
VEEV : 92.43 (+3.10%)
MASI : 108.79 (+0.34%)
Express Scripts Introduces Medicare PDP Offerings for 2019

Express Scripts' (ESRX) Medicare PDP to initiate coverage from Jan 1, 2019. The plan includes Walmart along with CVS Pharmacy and the Kroger Family of Pharmacies.

ESRX : 97.46 (+1.02%)
SRDX : 59.10 (+1.88%)
VEEV : 92.43 (+3.10%)
MASI : 108.79 (+0.34%)
Here's Why You Should Hold Ecolab Stock in Your Portfolio

Despite fluctuations in the cost of raw materials, Ecolab (ECL) to gain from strong performance in the Global Industrial segment.

SRDX : 59.10 (+1.88%)
VEEV : 92.43 (+3.10%)
MASI : 108.79 (+0.34%)
ECL : 158.31 (+0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade SRDX with:

Business Summary

SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring...

See More

Key Turning Points

2nd Resistance Point 62.13
1st Resistance Point 60.62
Last Price 59.10
1st Support Level 56.99
2nd Support Level 54.87

See More

52-Week High 82.35
Fibonacci 61.8% 60.44
Last Price 59.10
Fibonacci 50% 53.67
Fibonacci 38.2% 46.91
52-Week Low 25.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar